OOIR: Observatory of International Research

Papers

(The TQCC of Reviews in Endocrine & Metabolic Disorders is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Looking beyond fat in obesity: the frequently overlooked importance of muscle mass	142
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review	128
Pegvisomant in managing comorbidities of acromegaly: a review	121
Diagnostic and prognostic utility of phase angle in patients with cancer	113
Traumatic brain injury and prolactin	104
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review	98
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus	94
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality	79
Association between continuous glucose monitoring metrics and cardiovascular autonomic neuropathy in diabetic patients: a systematic review	65
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health	62
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus	62
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?	62
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb	61
The genetics of Graves’ disease	56
Endocrine responses of the stress system to different types of exercise	56
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review	55
Prolactin deficiency in the context of other pituitary hormone abnormalities	51
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic	50
Preface	49
Androgens, aging, and prostate health	48
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease	48
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond	47
Use of thermal imaging in the detection of the diabetic foot- review	46
Posttranslational modifications in diabetes: Mechanisms and functions	45
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease	43

Emerging role of AgRP neurons as integrators of metabolic, sensory and environmental cues in the control of energy homeostasis	42
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review	41
Mention to Prof. Andrew V. Schally	41
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries	40
Neurovascular plasticity as a modulator of hypothalamic function	40
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy	39
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis	39
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence	38
Appetitive interoception, the hippocampus and western-style diet	38
Deep neural network for food image classification and nutrient identification: A systematic review	37
No longer to be ignored: Hypophosphatemia following intravenous iron administration	37
Correction: Hypothalamic GHRH	36
Hypothalamic GHRH	36
Towards precision medicine in non-alcoholic fatty liver disease	35
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities	35
Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing’s syndrome: A systematic review and meta-analysis	35
Real-world evidence of effectiveness and safety of pasireotide in the treatment of acromegaly: a systematic review and meta-analysis	34
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome	34
LEAP2 as a therapeutic target in obesity and cardiometabolic disorders	33
Uterine fibroids in women diagnosed with acromegaly: a systematic review	32
The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations	32
Novel treatments for congenital adrenal hyperplasia	32
Regulation of adipogenesis by exosomal milk miRNA	31
Computational approaches to predicting treatment response to obesity using neuroimaging	30
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review	30
Food cue reactivity: Neurobiological and behavioral underpinnings	29
Bridging the gap: recommendations to accomplish transition from pediatric to adult care in adolescents living with obesity	29
Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection	28
Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): Clues, causes and consequences	28
Rathke’s cleft cyst: From history to molecular genetics	28
Correction to: Chemotherapy in NEN: still has a role?	27
Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects	27
Hypoprolactinemia, a neglected endocrine disorder	26
Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients	26
Prolactin: structure, receptors, and functions	24
GHRH in diabetes and metabolism	24
Endogenous Cushing’s syndrome during pregnancy	23
The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies	23
Molecular testing for thyroid nodules: Where are we now?	23
Phase angle in applications of bioimpedance in health and disease	22
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity	22
Phase angle as an index of physiological status: validating bioelectrical assessments of hydration and cell mass in health and disease	22
Phase angle in localized bioimpedance measurements to assess and monitor muscle injury	22
Gut-brain mechanisms underlying changes in disordered eating behaviour after bariatric surgery: a review	22
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group	21
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities	21
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions	21
Reference intervals for serum prolactin concentrations: analytical and clinical considerations	21
Contribution of the microbiome for better phenotyping of people living with obesity	21
BBSome: An essential component of hypothalamic regulation of energy homeostasis	21

Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications	21
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes	20
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management	20
Phase angle and COVID-19: A systematic review with meta-analysis	20
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases	20